Severity
Critical
FDA Drug recall · Reported February 11, 2026
Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil
Green Lumber Holdings, LLC recalled Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister pac… - a critical-severity action.
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister pac… was recalled by Green Lumber Holdings, LLC in February 11, 2026. Reason: Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil. Check the official notice for the remedy. Verify recall #D-0304-2026 with the FDA Drug before acting.
The recall
Green Lumber Holdings, LLC issued this critical-severity FDA Drug recall-Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil.
Sourced from official FDA Drug enforcement records. Verify recall #D-0304-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0304-2026) was formally reported on February 11, 2026, with the manufacturer initiating the action on August 28, 2025. It is classified under Critical severity (Class I), with a current status of Ongoing. Green Lumber Holdings, LLC is listed as the recalling firm, operating out of Corona Del Mar, CA. Federal records list the affected scope as N/A.
The documented reason for this recall is: Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
N/A
Related Recalls
6
5 from same agency
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San Miguel Drive, Suite #296, Newport Beach, CA 92660
Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Ongoing |
| Recall number | D-0304-2026 |
| Date reported | February 11, 2026 |
| Date initiated | August 28, 2025 |
| Recalling firm | Green Lumber Holdings, LLC |
| Firm location | Corona Del Mar, CA |
| Affected scope | N/A |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 11, 2026. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.